PFE logo Pfizer +
Pfizer
+

Pfizer (PFE) Business News

Track Pfizer in real time with a live news feed covering Pfizer stock news, official press releases, company announcements, and an archive of historical Pfizer news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection

Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far

Seeking Alpha

12:01 PM | Monday | Jul 27, 2026

news photo
Loading...

I initiate Pfizer with a contrarian BUY rating and a $32 price target for 2026 Q3-Q4. PFE's non-COVID portfolio demonstrates resilience, with Padcev, Vyndamax, and new launches driving operational growth despite patent cliffs. Padcev's July 2026 approval expands its addressable market, while pipeline assets like Berobenatide and PF-08634404 offer additional upside.

Read full article redirect
12:01 PM | Monday | Jul 27, 2026

Pfizer: Calling The Bottom - The Patent Cliff Is Real, But The Valuation Has Fallen Too Far

Seeking Alpha

I initiate Pfizer with a contrarian BUY rating and a $32 price target for 2026 Q3-Q4. PFE's non-COVID portfolio demonstrates resilience, with Padcev, Vyndamax, and new launches driving operational growth despite patent cliffs. Padcev's July 2026 approval expands its addressable market, while pipeline assets like Berobenatide and PF-08634404 offer additional upside.

Read full article arrow
News Thumbnail
3:54 AM | Monday | Jul 27, 2026

Gabelli Funds LLC Lowers Position in Pfizer Inc. $PFE

Defense World

Gabelli Funds LLC decreased its stake in shares of Pfizer Inc. (NYSE: PFE) by 11.8% in the undefined quarter, according to its most recent Form 13F filing with the SEC. The fund owned 508,600 shares of the biopharmaceutical company's stock after selling 67,900 shares during the period. Gabelli Funds LLC's holdings in Pfizer

Read full article arrow
News Thumbnail
6:27 AM | Sunday | Jul 26, 2026

Buy 4 Barron's Better Bets (Than T-Bills) Out Of 11 'Safer' July DiviDogs

Seeking Alpha

Verizon , Kinder Morgan, Regions Financial, and KeyCorp are the four buyable Barron's Better Bets Dogs, offering high, 'safest' dividends at fair prices. Analyst forecasts project net gains of 9.62% to 21.97% for top BBB Dogs by July 2027, with average net 13.68% on the top ten.
Six BBB Dogs show negative free cash flow margins, making their dividends potentially unsafe; Pfizer, ONEOK, Mid-America Apartment, Federal Realty, Williams Companies, and Entergy are flagged.

Read full article arrow
News Thumbnail
8:15 AM | Saturday | Jul 25, 2026

Pfizer's Dividend Yield Looks Almost Too Good. Here's Why Management Isn't Worried.

The Motley Fool

Pfizer is a large and well-respected pharmaceutical company. Pfizer has been facing headwinds, leaving investors worried about the dividend.

Read full article arrow
News Thumbnail
12:56 PM | Thursday | Jul 23, 2026

PFE's Talzenna sNDA Gets FDA Priority Tag in Wider Prostate Cancer Use

Zacks Investment Research

Pfizer's Talzenna plus Xtandi combo wins FDA priority review for HRR gene-mutated metastatic castration-sensitive prostate cancer.

Read full article arrow
News Thumbnail
8:13 AM | Thursday | Jul 23, 2026

Verizon Was Booted From the Dow – 5 Dividend Giants Got the Same Treatment and Eventually Soared

247 Wallst

Getting kicked off the Dow Jones Industrial Average sounds like a death sentence for a stock, but a handful of booted dividend giants went on to reward patient shareholders with stunning gains and steady income streams that index investors missed out on entirely.

Read full article arrow
News Thumbnail
3:47 AM | Thursday | Jul 23, 2026

Pfizer Inc. $PFE Shares Purchased by ABN Amro Investment Solutions

Defense World

ABN Amro Investment Solutions lifted its holdings in shares of Pfizer Inc. (NYSE: PFE) by 11.9% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 313,794 shares of the biopharmaceutical company's stock after purchasing an additional 33,262 shares during the quarter. ABN Amro

Read full article arrow
News Thumbnail
8:00 AM | Wednesday | Jul 22, 2026

2 Absurdly Cheap Healthcare Stocks to Buy Before July Ends

24/7 Wall Street

Healthcare is quietly becoming the value hunter's playground of 2026. While the mega cap tech trade keeps sucking up oxygen, two of the largest healthcare names in the S&P 500 are trading at forward multiples that look mispriced against their earnings power.

Read full article arrow
News Thumbnail
11:06 AM | Tuesday | Jul 21, 2026

What to Watch in Pfizer's Non-Oncology Portfolio This Earnings Season

Zacks Investment Research

Pfizer's non-oncology portfolio faced mixed Q2 trends. Eliquis and Vyndaqel sales may have risen while COVID products will have declined.

Read full article arrow
News Thumbnail
10:01 AM | Monday | Jul 20, 2026

Is Trending Stock Pfizer Inc. (PFE) a Buy Now?

Zacks Investment Research

Pfizer (PFE) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Read full article arrow
News Thumbnail